5-Amino-1MQ Certificate of Analysis (COA) Standards
In preclinical research, verifying the identity, chemical purity, and biological cleanliness of small molecule compounds is critical for experimental reproducibility. This document outlines the analytical standards, testing methodologies, and analytical metrics required on a lot-specific 5-Amino-1MQ Certificate of Analysis (COA). PX1 Research provides fully transparent, third-party laboratory verification for every lot synthesized to support rigorous in vitro and animal research protocols.
Quick answer
In preclinical research, verifying the identity, chemical purity, and biological cleanliness of small molecule compounds is critical for experimental reproducibility. This document outlines the analytical standards, testing methodologies, and analytical metrics required on a lot-specific 5-Amino-1MQ Certificate of Analysis (COA). PX1 Research provides fully transparent, third-party laboratory verification for every lot synthesized to support rigorous in vitro and animal research protocols.
Key takeaways
- 5-Amino-1-methylquinolinium ([5-Amino-1MQ](/research-peptides/5-amino-1mq)) is a selective, membrane-permeable small molecule inhibitor that has gained significant attention in metabolic and cellular biochemistry research.
- [5-Amino-1MQ](/research-peptides/5-amino-1mq) functions primarily as a potent, selective inhibitor of nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme responsible for methylating nicotinamide (NAM) using S-adenosylmethionine (SAM) as the methyl donor.
- In vitro data and rodent models indicate that suppressing NNMT activity with [5-Amino-1MQ](/research-peptides/5-amino-1mq) leads to a measurable increase in intracellular [NAD+](/research-peptides/nad-plus) levels.
- A credible [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) must provide raw, unfiltered analytical data generated by an independent, third-party testing laboratory.
Introduction to 5-Amino-1MQ and Analytical Verification Standards
5-Amino-1-methylquinolinium (5-Amino-1MQ) is a selective, membrane-permeable small molecule inhibitor that has gained significant attention in metabolic and cellular biochemistry research. Because small molecules and research peptides synthesized for laboratory settings can carry reaction byproducts, unreacted reagents, or degradation impurities, precise analytical documentation is essential before introducing these reagents into experimental assays.
A lot-specific Certificate of Analysis (COA) serves as the definitive analytical record of a chemical compound's physical and molecular profile. For investigators acquiring 5-Amino-1MQ, evaluating the COA ensures that observed biochemical phenomena derive solely from the target compound rather than extraneous contaminants. PX1 Research mandates that every batch undergoes comprehensive testing at accredited ISO 17025 third-party facilities prior to release.
Biochemical Mechanism: Nicotinamide N-Methyltransferase (NNMT) Inhibition
5-Amino-1MQ functions primarily as a potent, selective inhibitor of nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme responsible for methylating nicotinamide (NAM) using S-adenosylmethionine (SAM) as the methyl donor. NNMT activity directly regulates cellular energy metabolism by consuming SAM and converting NAM into N1-methylnicotinamide (MNAM), effectively draining the methyl pool and reducing the availability of substrates required for salvage synthesis of nicotinamide adenine dinucleotide (NAD+).
Preclinical studies suggest that targeted inhibition of NNMT by 5-Amino-1MQ blocks this methylation clearance pathway. By preserving intracellular nicotinamide pools, researchers can evaluate how NNMT suppression influences downstream metabolic signaling without directly supplying exogenous vitamin precursors. To explore broader metabolic assay design, consult our comprehensive research library covering enzymatic inhibition strategies.
Preclinical Focus: NAD+ Elevation, Mitochondrial Output, and Metabolic Research
In vitro data and rodent models indicate that suppressing NNMT activity with 5-Amino-1MQ leads to a measurable increase in intracellular NAD+ levels. NAD+ serves as a crucial coenzyme for mitochondrial electron transport, sirtuin activation, and poly(ADP-ribose) polymerase (PARP) repair pathways. Consequently, elevating endogenous NAD+ availability directly correlates with increased mitochondrial oxidative phosphorylation and ATP generation in cultured adipocytes and myotubes.
Additionally, preclinical models evaluating high-fat diet conditions demonstrate that NNMT inhibition supports fat-metabolism research by increasing basal metabolic rate and expression of key mitochondrial proteins, such as UCP1. Investigators evaluating intracellular bioenergetics often pair this compound with broader target panels available under our NAD+ metabolic research category.
Anatomy of a Legitimate 5-Amino-1MQ COA
A credible Certificate of Analysis must provide raw, unfiltered analytical data generated by an independent, third-party testing laboratory. A complete COA for 5-Amino-1MQ should explicitly state the lot number, manufacture date, testing date, chemical formula ($C_{10}H_{11}N_2^+$ or its salt form like $C_{10}H_{11}N_2I$), and theoretical molecular weight alongside measured laboratory metrics.
Legitimate COA documentation excludes proprietary self-policing or internal unverified testing claims. Key analytical sections must include High-Performance Liquid Chromatography (HPLC) chromatograms, Mass Spectrometry (MS) spectra, Bacterial Endotoxin Quantification (LAL assay), Physical Appearance/Solubility inspection, and Moisture Content determination via Karl Fischer titration.
High-Performance Liquid Chromatography (HPLC) Purity Testing
High-Performance Liquid Chromatography (HPLC) is the gold standard method for determining the chemical purity of small molecules like 5-Amino-1MQ. The technique separates the primary active compound from synthesis intermediates, residual solvents, structural isomers, and degradation products based on their interaction with a stationary column matrix under high pressure.
On a standard PX1 Research COA, the HPLC spectral report displays time-resolved absorbance peaks measured at specific UV wavelengths (typically 220 nm or 254 nm). Chemical purity is expressed as a Peak Area Percentage (% area), calculated by dividing the integrated peak area of 5-Amino-1MQ by the total integrated area of all detected peaks. For valid preclinical research, 5-Amino-1MQ must demonstrate an HPLC purity equal to or exceeding 98.0%, ensuring minimal interference in sensitive enzymatic and cell culture assays.
Mass Spectrometry (MS) Confirmation and Molecular Structure Verification
While HPLC confirms relative purity and the absence of secondary peaks, it does not prove chemical identity. Mass Spectrometry (MS)—frequently utilizing Electrospray Ionization (ESI-MS)—is required to confirm the precise molecular mass of the target ion. The resulting mass spectrum plots mass-to-charge ratios ($m/z$) against relative signal abundance.
For 5-Amino-1MQ (cationic theoretical mass of approximately 159.10 g/mol for $C_{10}H_{11}N_2^+$), the primary observed peak in positive ion mode ($[M]^+$ or $[M+H]^+$) must match the calculated monoisotopic mass within tight resolution tolerances (typically $\pm 0.5$ Da). A complete COA displays the actual mass spectral plot, confirming that the synthesized molecule possesses the exact structural identity required for high-specificity NNMT inhibitor studies.
Endotoxin Testing and Bioburden Analysis
Bacterial endotoxins—primarily lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are potent pyrogens capable of inducing inflammatory cascades, altering gene expression, and causing cell toxicity in laboratory models. Even minor endotoxin contamination can completely invalidate cell culture research or in vitro metabolic experiments by triggering non-specific immune responses.
PX1 Research subjects every batch of 5-Amino-1MQ to quantitative Chromogenic Limulus Amebocyte Lysate (LAL) testing or recombinant Factor C assays. A passing COA must explicitly state the endotoxin level in Endotoxin Units per milligram (EU/mg), with standard preclinical acceptance limits set strictly below 0.1 EU/mg (or < 0.05 EU/mg for sterile culture applications).
Physical Characteristics: Appearance, Moisture Content, and Solubility
Beyond molecular metrics, physical quality attributes dictate the material's handling and stability in the laboratory. The COA must document the visual physical appearance—typically a crystalline, off-white to pale yellow or orange powder, depending on the salt counterpart (e.g., iodide or bromide salt). Any discoloration or clumping beyond standard chemical characteristics indicates potential thermal degradation or atmospheric moisture exposure.
Moisture content is quantified using Karl Fischer (KF) volumetric or coulometric titration. Excessive water retention accelerates hydrolytic degradation and distorts molecular weight calculations when preparing volumetric stock solutions. A rigorous COA limits residual moisture content to less than 1.0% to 2.0% w/w. Furthermore, basic solubility profiles (e.g., clear solution in DMSO or sterile deionized water at specified concentrations) confirm proper solid-state physical properties.
Comparative Analysis: 5-Amino-1MQ vs. Related Metabolic Research Compounds
When designing preclinical protocols focused on cellular energetics, mitochondrial function, and lipid oxidation, researchers often evaluate several complementary active compounds. Selecting the appropriate biochemical probe depends on whether targeted enzymatic inhibition or direct pathway activation is required.
While 5-Amino-1MQ acts upstream via selective cytosolic NNMT inhibition to preserve NAD+ pools, compounds such as MOTS-c function as mitochondrial-derived peptides that regulate nuclear gene expression and metabolic homeostasis directly. Similarly, AICAR acts as a direct cell-permeable activator of AMP-activated protein kinase (AMPK), stimulating glucose uptake and fatty acid oxidation independently of NNMT. Comparing these mechanisms within our broader mitochondrial research peptides panel allows investigators to isolate specific regulatory nodes in energy metabolism.
PX1 Research Quality Assurance, ISO 17025 Accreditation, and Sourcing
PX1 Research operates strictly within a quality management framework designed to meet the rigorous demands of institutional laboratories, universities, and private research organizations. All compounds are synthesized in state-of-the-art facilities compliant with Good Manufacturing Practice (GMP) standards within the United States.
Every production lot undergoes independent verification at an ISO 17025 accredited analytical facility. We issue transparent, lot-matched COAs with full spectral data available directly to verified researchers. Laboratories managing high-throughput projects or requiring bulk quantities can apply for specialized institutional access through our wholesale laboratory accounts portal.
Storage, Reconstitution, and Laboratory Handling Best Practices
Proper handling and storage conditions are essential to preserve the chemical stability of 5-Amino-1MQ following analytical verification. Lyophilized or solid-state powder should be stored in tightly sealed, light-resistant containers at $-20^\circ\text{C}$ or $-80^\circ\text{C}$ to prevent ambient moisture absorption and photo-oxidation.
For laboratory reconstitution, 5-Amino-1MQ is readily soluble in dimethyl sulfoxide (DMSO) or high-purity laboratory grade solvents. Reconstituted stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles and stored at $-80^\circ\text{C}$. All handling must be conducted under aseptic conditions in a laminar flow hood using appropriate personal protective equipment (PPE). All products supplied by PX1 Research are strictly designated for laboratory research use only and are not for human or animal clinical application.
Frequently Asked Questions
What is the primary mechanism of action for 5-Amino-1MQ in preclinical research?
5-Amino-1MQ is a selective small molecule inhibitor of nicotinamide N-methyltransferase (NNMT). By inhibiting NNMT, it prevents the methylation clearance of nicotinamide, leading to elevated intracellular NAD+ levels and improved mitochondrial output in experimental models.
What purity threshold should a valid 5-Amino-1MQ COA show?
A valid COA for research-grade 5-Amino-1MQ should demonstrate a minimum High-Performance Liquid Chromatography (HPLC) chemical purity of 98.0%, with ideal batches reaching >99.0%.
How is the molecular identity of 5-Amino-1MQ verified on the COA?
Molecular identity is confirmed using Mass Spectrometry (MS), specifically Electrospray Ionization (ESI-MS). The spectrum must display a mass-to-charge ratio ($m/z$) corresponding to the target cation ($[M]^+$ at ~159.10 Da) within strict resolution limits.
Why is endotoxin testing critical for 5-Amino-1MQ in laboratory research?
Bacterial endotoxins (LPS) cause non-specific inflammatory responses and cytotoxicity in cell culture and animal models. COAs must specify endotoxin levels verified via LAL testing, typically keeping limits under 0.1 EU/mg to ensure experimental validity.
How does 5-Amino-1MQ differ from MOTS-c and AICAR in metabolic research?
5-Amino-1MQ acts as an NNMT inhibitor to preserve intracellular NAD+ pools, whereas MOTS-c is a mitochondrial-derived peptide influencing nuclear gene expression, and AICAR is a direct chemical activator of AMPK.
What method is used to measure residual moisture on a 5-Amino-1MQ COA?
Residual moisture is measured using Karl Fischer (KF) titration. A pass result ensures moisture levels remain below 1.0%–2.0% w/w, preventing hydrolytic degradation and ensuring accurate mass measurements.
How should reconstituted 5-Amino-1MQ stock solutions be stored in the laboratory?
Reconstituted stock solutions (typically in DMSO) should be divided into single-use aliquots and stored at $-80^\circ\text{C}$ to protect against hydrolytic degradation and reduce damage from repeated freeze-thaw cycles.
Where are PX1 Research compounds synthesized and tested?
All PX1 Research compounds are synthesized in USA-based, GMP-compliant facilities and undergo independent third-party analytical testing at accredited ISO 17025 laboratories.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.